Written by
Şevval T
Şevval T Liv Hospital Content Team
Medically reviewed by

Related Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Liv Hospital Ulus Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics Spec. MD. Gizem Güvener Liv Hospital Ulus Spec. MD. Gizem Güvener Pediatrics Spec. MD. Osman Karlı Liv Hospital Ulus Spec. MD. Osman Karlı Pediatrics Spec. MD. Tamer Ünver Liv Hospital Ulus Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU) Assoc. Prof. MD. Adem Dursun Liv Hospital Vadistanbul Assoc. Prof. MD. Adem Dursun Pediatrics Psyc. Selenay Yücel Keleş Liv Hospital Vadistanbul Psyc. Selenay Yücel Keleş Pediatric Psychology Spec. MD.  Fatih Aydın Liv Hospital Vadistanbul Spec. MD. Fatih Aydın Pediatrics Spec. MD. Dicle Çelik Liv Hospital Vadistanbul Spec. MD. Dicle Çelik Pediatrics Spec. MD. Elif Erdem Özcan Liv Hospital Vadistanbul Spec. MD. Elif Erdem Özcan Pediatrics Spec. MD. Hilal Kızıldağ Liv Hospital Vadistanbul Spec. MD. Hilal Kızıldağ Pediatrics Spec. MD. Mehmet Kılıç Liv Hospital Vadistanbul Spec. MD. Mehmet Kılıç Pediatrics Spec. MD. Ozan Uzunhan Liv Hospital Vadistanbul Spec. MD. Ozan Uzunhan Neonatology Spec. MD. Selami Bayrakdar Liv Hospital Vadistanbul Spec. MD. Selami Bayrakdar Pediatrics Spec. MD. Semra Akkuş Akman Liv Hospital Vadistanbul Spec. MD. Semra Akkuş Akman Pediatrics Asst. Prof. MD. Doruk Gül Liv Hospital Bahçeşehir Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases Prof. MD. Murat Sütçü Liv Hospital Bahçeşehir Prof. MD. Murat Sütçü Pediatric Health and Diseases Prof. MD. Nihat Demir Liv Hospital Bahçeşehir Prof. MD. Nihat Demir Pediatrics Psyc. (Psychologist) Buse Yağmur Liv Hospital Bahçeşehir Psyc. (Psychologist) Buse Yağmur Pediatric Psychology Spec. MD. Cansu Muluk Liv Hospital Bahçeşehir Spec. MD. Cansu Muluk Pediatrics Spec. MD. Dilek Hatipoğlu Liv Hospital Bahçeşehir Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases Spec. MD. Duygu Amine Garavi Liv Hospital Bahçeşehir Spec. MD. Duygu Amine Garavi Pediatrics Spec. MD. Fatih Kaya Liv Hospital Bahçeşehir Spec. MD. Fatih Kaya Pediatric Health and Diseases Spec. MD. Günel Nüsretzade Elmar Liv Hospital Bahçeşehir Spec. MD. Günel Nüsretzade Elmar Pediatrics Spec. MD. Mey Talip Liv Hospital Bahçeşehir Spec. MD. Mey Talip Pediatric Intensive Care Spec. MD. Negın Nahanmoghaddam Liv Hospital Bahçeşehir Spec. MD. Negın Nahanmoghaddam Pediatrics Spec. MD. Nushaba Abdullayeva Liv Hospital Bahçeşehir Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases Spec. MD. Refika İlbakan Hanımeli Liv Hospital Bahçeşehir Spec. MD. Refika İlbakan Hanımeli Pediatrics Spec. MD. Selman Alazab Liv Hospital Bahçeşehir Spec. MD. Selman Alazab Pediatrics Spec. MD. Özden Durmuş Gönültaş Liv Hospital Bahçeşehir Spec. MD. Özden Durmuş Gönültaş Pediatrics Spec. Md. Öznur Ceylan Liv Hospital Bahçeşehir Spec. Md. Öznur Ceylan Pediatric Health and Diseases Assoc. Prof. MD. Aslan Yılmaz Liv Hospital Topkapı Assoc. Prof. MD. Aslan Yılmaz Neonatology Prof. MD. Alpay Çakmak Liv Hospital Topkapı Prof. MD. Alpay Çakmak Pediatrics Spec. MD. Demet Deniz Bilgin Liv Hospital Topkapı Spec. MD. Demet Deniz Bilgin Pediatrics Spec. MD. Nesrin Köseoğlu Liv Hospital Topkapı Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry Spec. MD. Seçil Sözen Liv Hospital Topkapı Spec. MD. Seçil Sözen Pediatrics Spec. MD. Özge Akça Liv Hospital Topkapı Spec. MD. Özge Akça Pediatrics Spec. MD. Şeyma Öz Liv Hospital Topkapı Spec. MD. Şeyma Öz Pediatrics Asst. Prof. MD. Pakize Elif Alkış Liv Hospital Ankara Asst. Prof. MD. Pakize Elif Alkış Pediatrics Prof. MD. Musa Kazım Çağlar Liv Hospital Ankara Prof. MD. Musa Kazım Çağlar Pediatrics Prof. MD. İbrahim Hakan Bucak Liv Hospital Ankara Prof. MD. İbrahim Hakan Bucak Pediatrics Prof.MD. Sevgi Başkan Liv Hospital Ankara Prof.MD. Sevgi Başkan Pediatrics Spec. MD. Büşra Süzen Celbek Liv Hospital Ankara Spec. MD. Büşra Süzen Celbek Pediatrics Spec. MD. Galip Erdem Liv Hospital Ankara Spec. MD. Galip Erdem Pediatrics Spec. MD. Hafsa Uçur Liv Hospital Ankara Spec. MD. Hafsa Uçur Pediatric Health and Diseases Spec. MD. Hidayet Katipoğlu Liv Hospital Ankara Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases Spec. MD. Hüsniye Altan Liv Hospital Ankara Spec. MD. Hüsniye Altan Pediatrics Spec. MD. Mehmet Turfanda Liv Hospital Ankara Spec. MD. Mehmet Turfanda Pediatric Health and Diseases Spec. MD. Mustafa Yücel Kızıltan Liv Hospital Ankara Spec. MD. Mustafa Yücel Kızıltan Pediatrics Spec. MD.  Seral Navdar Liv Hospital Gaziantep Spec. MD. Seral Navdar Pediatric Health and Diseases Spec. MD. Gül Balyemez Liv Hospital Gaziantep Spec. MD. Gül Balyemez Pediatric Health and Diseases Spec. MD. Hasan Avşar Liv Hospital Gaziantep Spec. MD. Hasan Avşar Neonatology Spec. MD. Mert Çakır Liv Hospital Gaziantep Spec. MD. Mert Çakır Pediatrics Spec. MD. Saltuk Buğra Böke Liv Hospital Gaziantep Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases Spec. MD. Özlem Karaoğlu Liv Hospital Gaziantep Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases Spec. MD. İsmail Ersan Can Liv Hospital Gaziantep Spec. MD. İsmail Ersan Can Pediatric Health and Diseases Spec. MD. Şekibe Zehra Doğan Liv Hospital Gaziantep Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases Spec. MD. Gülsenem Sarı Aracı Liv Hospital Samsun Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases Spec. MD. Nazlı Karakullukcu Çebi Liv Hospital Samsun Spec. MD. Nazlı Karakullukcu Çebi Pediatrics Spec. MD. Nezih Akgün Liv Hospital Samsun Spec. MD. Nezih Akgün Pediatric Health and Diseases Spec. MD. Pelin Aytaç Uras Liv Hospital Samsun Spec. MD. Pelin Aytaç Uras Pediatrics MD. VEFA İSAYEVA Liv Bona Dea Hospital Bakü MD. VEFA İSAYEVA Pediatric Health and Diseases Spec. MD.  Elnur Hüseynov Liv Bona Dea Hospital Bakü Spec. MD. Elnur Hüseynov Pediatrics Spec. MD. INARE ELDAROVA Liv Bona Dea Hospital Bakü Spec. MD. INARE ELDAROVA Pediatrics Spec. MD. SADİQ İSMAYILOV Liv Bona Dea Hospital Bakü Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases MD. Dr. Elnur Hüseynov MD. Dr. Elnur Hüseynov Pediatrics Spec. MD. Doğa Sevinçok Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry Spec. MD. Sadık İsmayılov Pediatrics Spec. MD. Melike Akar Liv Hospital Bahçeşehir + Liv Hospital Topkapı Spec. MD. Melike Akar Pediatrics
...
Views
Read Time
...
views
Read Time
 Find Out: What is the second name for Wilms tumor? Nephroblastoma
 Find Out: What is the Second Name for Wilms tumor? Nephroblastoma 4

Wilms tumor is a rare kidney cancer that mainly hits kids. It’s also called nephroblastoma. This name is very important for doctors to diagnose and treat it.

Clarifying the medical terminology: What is the second name for Wilms tumor? and its origin.

In healthcare, clear talk is super important, even with serious issues like Wilms tumor or nephroblastoma. Knowing the names and terms for this disease helps patients and families understand their care better.

Key Takeaways

  • Wilms tumor is also known as nephroblastoma.
  • It’s a rare kidney cancer that mainly affects kids.
  • Understanding wilms cancer terminology is key for diagnosis and treatment.
  • Kidney tumor synonyms like nephroblastoma help identify the condition.
  • Clear communication is vital in managing care for Wilms tumor.

Understanding Wilms Tumor: An Overview

 Find Out: What is the second name for Wilms tumor? Nephroblastoma
 Find Out: What is the Second Name for Wilms tumor? Nephroblastoma 5

It’s important to understand Wilms tumor for early detection and effective treatment. This is because it’s a common kidney tumor in kids. Wilms tumor, also known as nephroblastoma, is a rare cancer that mostly affects children under 7.

Definition and Basic Characteristics

Wilms tumor is a rare kidney tumor that mainly hits young kids. It grows fast and can spread to other parts of the body if not treated quickly. The tumor starts in the kidneys, which are key organs for filtering waste from the blood.

The basic traits of Wilms tumor include its usual form as a big, one-sided mass in the belly. It can be linked to genetic mutations and some birth defects.

Prevalence and Significance

Wilms tumor is a big part of pediatric kidney cancer cases. This makes it a key area to study in pediatric oncology. Even though it’s rare, it’s the most common kidney tumor in kids.

The importance of Wilms tumor comes from its commonness in childhood cancers. It also comes from the challenges in diagnosing and treating it. Early detection and a detailed treatment plan are key to better outcomes for kids with this condition.

What is the Second Name for Wilms Tumor?

 Find Out: What is the second name for Wilms tumor? Nephroblastoma
 Find Out: What is the Second Name for Wilms tumor? Nephroblastoma 6

Wilms tumor and nephroblastoma are the same kidney cancer. They are often confused, but it’s because of old medical terms.

Nephroblastoma: The Medical Terminology

Nephroblastoma is the medical term for Wilms tumor, a cancer mostly in kids. It comes from “nephros,” meaning kidney, and “blastoma,” a cancerous tumor. This name clearly shows where and what the tumor is.

“Nephroblastoma is used more in medical papers,” says a pediatric oncologist. “It’s more precise and accurate.”

Why Two Different Names Exist

The reason for two names is the disease’s history and how medical terms have changed. Wilms tumor was named after Max Wilms, a German surgeon from the late 19th century. As science grew, “nephroblastoma” became the preferred term for its accuracy.

Even though “nephroblastoma” is preferred in medical texts, “Wilms tumor” is also well-known. This shows how old and new medical terms meet.

Historical Background of Wilms Tumor Naming

Exploring the history of Wilms tumor naming shows Max Wilms’ key role. It also highlights how medical terms have changed over time. Wilms tumor, or nephroblastoma, is a major issue in pediatric nephrology cancer affecting kids globally.

Max Wilms and His Discovery

Max Wilms, a German surgeon, first described the tumor in the late 19th century. His work was the start of understanding this congenital kidney tumor. It’s now a key area in childhood oncology.

Wilms did more than just describe the tumor. His research helped others study it more. This led to better ways to diagnose and treat it.

Evolution of Medical Terminology

Over years, doctors have used different names for this condition. “Wilms tumor” honors Max Wilms, while “nephroblastoma” shows it’s a kidney tumor.

The use of both names shows how medical terms evolve. It’s influenced by the discovery’s history and new findings. Today, both names are common in pediatric nephrology. They show the mix of old and new in medicine.

Learning about Wilms tumor’s naming history is a tribute to early researchers. It also gives us insight into today’s understanding and treatment of this childhood oncology tumor.

Epidemiology of Nephroblastoma

The study of nephroblastoma gives us key insights into its spread, age, and gender patterns. It’s a rare kidney tumor mainly found in kids. Knowing these facts is important for research and helping doctors.

Global Incidence Rates

Nephroblastoma, or Wilms tumor, hits about 1 in 10,000 kids globally. It’s not common, but it’s a top kidney cancer in kids. The rates vary by population and ethnicity, showing how genes and environment play a role.

Research shows nephroblastoma rates are mostly the same worldwide, with some exceptions. For example, Africa and Asia have slightly different rates than Western countries. This shows why studying it globally is key.

Age and Gender Distribution

Nephroblastoma mostly hits young kids, with most cases in those under 7. The highest number of cases is between 3 and 4 years old. This suggests a strong genetic link, as it often appears early in life.

When it comes to gender, nephroblastoma’s rates are mostly even between boys and girls. But, some studies find a slight difference in certain groups. Knowing this helps doctors and researchers find and tackle risk factors.

Looking into nephroblastoma’s spread and who it affects helps us understand this rare tumor better. This knowledge is vital for finding better ways to diagnose and treat it in kids.

Genetic Factors and Risk Associations

Wilms tumor, or nephroblastoma, is a complex condition influenced by genetic factors. These factors contribute to its onset and progression. Understanding these genetic underpinnings is essential for identifying individuals at higher risk. It also helps inform treatment strategies.

Genetic Mutations Linked to Wilms Tumor

Specific genetic mutations have been associated with an increased risk of developing Wilms tumor. One of the most well-known mutations involves the WT1 gene. This gene plays a critical role in renal development. Mutations in this gene can lead to abnormal cell growth and tumor formation.

Other genetic alterations, such as those affecting the CTNNB1 gene, have also been implicated in the pathogenesis of Wilms tumor. These mutations can disrupt normal cellular processes. They contribute to tumor development.

Associated Syndromes and Conditions

Certain genetic syndromes are associated with an increased risk of Wilms tumor. For example, children with WAGR syndrome (Wilms tumor, Aniridia, Genitourinary anomalies, and mental Retardation) are at higher risk. This is due to a deletion on chromosome 11p13 that affects the WT1 gene.

Other conditions, such as Beckwith-Wiedemann syndrome and Denys-Drash syndrome, also have an increased risk of Wilms tumor. These conditions have genetic mutations that predispose to abnormal growth and tumor formation.

Syndrome/ConditionGenetic MutationRisk Association
WAGR SyndromeDeletion on chromosome 11p13High risk of Wilms tumor
Beckwith-Wiedemann SyndromeAlterations on chromosome 11p15Increased risk of Wilms tumor and other tumors
Denys-Drash SyndromeMutations in the WT1 geneHigh risk of Wilms tumor and renal failure

Understanding these genetic factors and associated syndromes is key for early detection and management of Wilms tumor. Genetic counseling and screening can help identify children at higher risk. This allows for timely intervention.

Clinical Presentation and Symptoms

Childhood nephroblastoma shows different signs. Wilms tumor often grows big before it’s found. Its signs can vary a lot.

Common Signs and Symptoms

Children with Wilms tumor might have swelling or pain in their belly. They could also have blood in their urine. Less often, they might feel feverish, have high blood pressure, or lose their appetite.

It’s key for parents to know these signs. Finding them early can really help with treatment. Here’s a table with common symptoms:

SymptomFrequencyClinical Significance
Abdominal Swelling/MassCommonOften the first noticeable sign
Abdominal PainCommonCan be due to tumor growth or hemorrhage
HematuriaLess CommonIndicates possible tumor invasion into the urinary tract
FeverLess CommonMay indicate tumor necrosis or infection
HypertensionLess CommonCan be due to renal ischemia or tumor secretion

When to Seek Medical Attention

If a child shows signs like belly swelling or pain, get help fast. Early treatment of Wilms tumor can greatly improve chances.

Parents should see a doctor if they notice any odd signs in their child. A full check-up can find the cause and start the right treatment.

Diagnostic Approaches for Nephroblastoma

Identifying nephroblastoma requires a detailed approach. We use advanced imaging and lab tests. Accurate diagnosis is key for effective treatment.

Imaging Techniques

Imaging is essential for diagnosing nephroblastoma. We use different methods to see the tumor and its size.

  • Ultrasound: Often the first test, ultrasound helps spot the tumor.
  • Computed Tomography (CT) Scan: A CT scan gives detailed views of the abdomen. It shows the tumor’s size and if it has spread.
  • Magnetic Resonance Imaging (MRI): MRI provides detailed images. It’s great for checking the tumor’s relation to nearby structures.

Laboratory Tests

Laboratory tests are vital for diagnosing nephroblastoma. They help rule out other conditions. These tests include:

  • Complete Blood Count (CBC): Checks for anemia or infection signs.
  • Blood Chemistry Tests: Assesses kidney function and metabolic health.
  • Urinalysis: Looks for blood or other urine abnormalities.

Biopsy and Histological Examination

A biopsy is the main way to diagnose nephroblastoma. It removes a tumor sample for examination.

Nephroblastoma’s histological features vary. The tumor usually has blastemal, epithelial, and stromal elements. The mix of these elements affects the tumor’s type and prognosis.

Histological ComponentDescriptionPrognostic Significance
BlastemalUndifferentiated cells that are highly proliferativeHigher proportion may indicate a more aggressive tumor
EpithelialCells forming tubular or glomerular structuresPresence can indicate a more favorable prognosis
StromalConnective tissue elementsVariability in stromal component can affect tumor behavior

By combining imaging, lab tests, and histological examination, we can accurately diagnose nephroblastoma. This helps us create a treatment plan for each patient.

Staging and Classification Systems

Staging and classification of Wilms tumor are key in pediatric oncology. They help decide treatment and predict outcomes. It’s important for doctors, patients, and families to understand these systems.

National Wilms Tumor Study Group Staging

The National Wilms Tumor Study Group (NWTSG) staging system is used to classify Wilms tumor. It helps predict the prognosis and plan treatment.

The NWTSG system divides Wilms tumor into five stages:

StageDescription
IThe tumor is limited to the kidney and is completely excised.
IIThe tumor extends beyond the kidney but is completely removed surgically.
IIIThe tumor is not completely removed surgically, or there are positive lymph nodes.
IVThe tumor has metastasized to distant organs such as the lungs, liver, or brain.
VBilateral kidney involvement at diagnosis.

Histological Classification

Wilms tumor is also classified based on its histological characteristics. The histology is a key factor in predicting the prognosis. Tumors are classified as having favorable or unfavorable histology.

Favorable Histology: Tumors with favorable histology have a better prognosis. They appear more differentiated under the microscope.

Unfavorable Histology: Tumors with anaplasia, showing large, hyperchromatic nuclei, have unfavorable histology. These tumors are more aggressive and have a poorer prognosis.

Knowing the stage and histological classification of Wilms tumor is vital. It helps in creating an effective treatment plan and gives accurate prognostic information to patients and their families.

Treatment Modalities for Wilms Tumor

Managing pediatric renal neoplasm requires several key treatments. Wilms tumor, or nephroblastoma, is treated with surgery, chemotherapy, and sometimes radiation. This depends on the tumor’s stage and type.

Surgical Interventions

Surgery is key in treating Wilms tumor. The main surgery is a radical nephrectomy. This means removing the affected kidney, adrenal gland, and nearby tissues.

In some cases, nephron-sparing surgery is used. This is for patients with bilateral Wilms tumor or those with only one kidney.

The surgery type depends on the tumor’s size, location, and spread. Surgeons also consider the patient’s health and other factors.

Chemotherapy Protocols

Chemotherapy is vital in treating Wilms tumor. It kills cancer cells left after surgery or shrinks the tumor before surgery. The treatment plan varies based on the tumor’s stage, type, and patient response.

Chemotherapy agents like vincristine, dactinomycin, and doxorubicin are used. The treatment length and type are tailored to each patient, following established protocols.

Radiation Therapy Considerations

Radiation therapy is sometimes used for Wilms tumor, mainly for higher-stage disease or unfavorable histology. The decision is based on the tumor’s characteristics and the patient’s health.

Radiation helps control the tumor and lower recurrence risk. The dosage and delivery method are planned to be effective while minimizing side effects.

Treatment ModalityDescriptionConsiderations
SurgeryRadical nephrectomy or nephron-sparing surgeryTumor size, location, patient’s overall health
ChemotherapyVincristine, dactinomycin, doxorubicinStage, histology, patient’s response
Radiation TherapyExternal beam radiationHigher-stage disease, unfavorable histology

Effective Wilms tumor treatment needs a team effort. Pediatric oncologists, surgeons, radiologists, and others work together. This combination of treatments improves outcomes for children with this malignant tumor.

Prognosis and Survival Rates

We will look at what affects the prognosis and survival rates for kids with Wilms tumor. The outlook for childhood nephroblastoma has gotten much better. This is thanks to new medical treatments and a deeper understanding of the disease.

The survival rate for Wilms tumor is about 90% in places with good healthcare. This shows how well current treatments work. The success comes from using a mix of surgery, chemotherapy, and radiation therapy.

Factors Affecting Prognosis

Several things can change a child’s outlook if they have renal tumor in kids. These include:

  • The stage of the disease at diagnosis
  • The histology of the tumor (favorable or unfavorable)
  • The age of the child at diagnosis
  • The response to initial treatment

Children with a tumor that looks good under the microscope and are caught early usually do well. On the other hand, kids with kidney malignancy children who have a bad-looking tumor or are diagnosed late face tougher challenges.

Long-term Survival Statistics

Good news for Wilms tumor: most kids survive long-term. Studies show that over 85% of kids live for at least 5 years after diagnosis. This number can change based on the tumor’s stage and type.

We keep working on better treatments to boost these numbers. Research into the genetic and molecular reasons behind childhood nephroblastoma is key. It helps us find more precise and effective treatments.

Understanding what affects survival helps doctors give better care to kids with Wilms tumor and their families.

Long-term Follow-up and Complications

Managing Wilms tumor, also known as nephroblastoma or renal blastoma, goes beyond the initial treatment. It involves ongoing care. This care is essential for those with congenital kidney tumors.

Long-term follow-up is key for several reasons. It helps doctors watch for tumor return and manage treatment side effects.

Monitoring for Recurrence

Regular check-ups are vital for catching any tumor return early. This includes:

  • Imaging studies, such as ultrasound or CT scans
  • Laboratory tests to check for tumor markers
  • Physical examinations to monitor overall health

Finding recurrence early can greatly improve treatment success. A leading oncologist notes, “The key to managing recurrence lies in early detection through diligent follow-up care.”

“Surveillance is our best tool against recurrence.”

Late Effects of Treatment

Treatment for Wilms tumor can affect a child’s health long-term. This includes:

  1. Renal dysfunction due to the removal or irradiation of kidney tissue
  2. Increased risk of secondary cancers
  3. Growth and developmental issues

It’s important to have ongoing care to lessen these risks. A follow-up plan should be made for each patient, considering their treatments.

In summary, long-term follow-up care is vital for managing Wilms tumor. It helps monitor for recurrence and manage treatment side effects. This way, we can improve outcomes for children with this condition.

Psychosocial Impact on Children and Families

Getting a Wilms tumor diagnosis changes everything for kids and their families. It brings emotional and psychological hurdles. The journey through diagnosis, treatment, and recovery is filled with uncertainty, fear, and big lifestyle changes.

Emotional and Psychological Challenges

Children with Wilms tumor, or nephroblastoma, face many emotions. They might feel anxious, depressed, angry, or scared. The treatment, which includes surgery, chemotherapy, and radiation, is long and tough. It affects their life quality and mental health.

Families also face big emotional and psychological hurdles. Parents might feel stressed, anxious, and helpless while supporting their child. Siblings can feel left out or struggle to understand what’s happening.

Key Emotional and Psychological Challenges:

  • Anxiety and depression in children
  • Stress and anxiety in parents
  • Feelings of isolation or neglect in siblings

Support Resources and Coping Strategies

There are many support resources for kids and families dealing with Wilms tumor. These include counseling, support groups, and educational materials.

Support ResourceDescriptionBenefit
Psychological CounselingProfessional counseling for children and familiesReduces anxiety and depression, improves coping mechanisms
Support GroupsGroups for families to share experiencesFosters a sense of community, reduces feelings of isolation
Educational ResourcesInformation on Wilms tumor and its treatmentEmpowers families with knowledge, reduces uncertainty

Good coping strategies include talking openly in the family, getting help from healthcare pros, and doing things that relax and reduce stress.

By understanding the psychosocial effects of Wilms tumor and using support resources, kids and families can face its challenges better. This improves their overall well-being and life quality.

Recent Advances in Nephroblastoma Research

Our understanding of pediatric renal neoplasm is growing. Researchers are finding new ways to help patients. They are using genetic research, clinical trials, and new technologies.

Emerging Treatment Approaches

Targeted therapies for malignant renal tumors like nephroblastoma are being developed. Scientists are finding specific genetic mutations. This helps create treatments that target cancer cells more precisely.

Immunotherapy is another promising area. It uses the body’s immune system to fight cancer. Researchers are looking into different ways to use it, like checkpoint inhibitors and CAR-T cell therapy, for renal embryonal tumors.

Promising Research Directions

Research into Wilms tumor genetics is showing great promise. Scientists have found genes linked to nephroblastoma. This helps identify high-risk patients and guides new treatments.

New imaging technologies are also helping. They give detailed info about tumors. This helps doctors plan better treatments for pediatric renal neoplasms.

We’re hopeful about the future of nephroblastoma treatment. Ongoing studies and trials are key. We look forward to better care for children with this disease.

Conclusion

Understanding Wilms tumor, also known as nephroblastoma, is key in pediatric kidney cancer. We’ve looked at its definition, history, diagnosis, treatment, and outlook. Wilms tumor is complex and needs a detailed approach. This includes looking at genetics, symptoms, and how far the cancer has spread. New research and treatments offer hope for better care for kids with this disease. We’ve learned how vital it is to keep researching and spreading the word about Wilms tumor and nephroblastoma. This knowledge helps us better understand and support kids and their families dealing with this cancer.

FAQ

What is Wilms tumor, and what is its second name?

Wilms tumor, also known as nephroblastoma, is a rare kidney cancer in kids. It usually affects children under seven. It starts in the kidneys.

What are the common signs and symptoms of Wilms tumor?

Signs include a swelling in the abdomen and pain. Kids might also have fever, nausea, and vomiting. Some may have high blood pressure or blood in their urine.

How is Wilms tumor diagnosed?

Doctors use ultrasound, CT scans, and MRI scans to find Wilms tumor. They also do lab tests and a biopsy. This confirms the diagnosis.

What are the treatment options for Wilms tumor?

Treatment includes surgery, chemotherapy, and sometimes radiation. The plan depends on the tumor’s stage and type. It’s made just for the child.

What is the prognosis for children diagnosed with Wilms tumor?

Kids with Wilms tumor have a good chance of survival. In developed countries, survival rates are 85% to 90%. The disease’s stage and how well it responds to treatment matter.

Are there any genetic factors associated with Wilms tumor?

Yes, some genetic mutations increase the risk. These include WT1 gene mutations and syndromes like WAGR and Denys-Drash.

How is Wilms tumor staged?

Staging looks at the tumor’s size and spread. The National Wilms Tumor Study Group system is used.

What is the importance of long-term follow-up for children with Wilms tumor?

Follow-up is key for catching any return of the tumor. It also helps manage treatment side effects. Regular check-ups are important for the child’s health.

How does Wilms tumor affect families emotionally and psychologically?

A diagnosis can be tough for families. They need support and counseling. This helps them cope with the journey.

What are the recent advances in nephroblastoma research?

New research includes targeted therapy and genetic studies. Clinical trials aim to improve treatment outcomes for kids with Wilms tumor.

What is the significance of understanding Wilms tumor and its alternative name, nephroblastoma?

Knowing about Wilms tumor and nephroblastoma helps raise awareness. It ensures accurate diagnosis and treatment. It also helps families and doctors talk about the condition.

References

i

Medical Disclaimer

The content on this page is for informational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Always consult a qualified healthcare provider regarding any medical conditions.

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
GDPR

Related Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Liv Hospital Ulus Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics Spec. MD. Gizem Güvener Liv Hospital Ulus Spec. MD. Gizem Güvener Pediatrics Spec. MD. Osman Karlı Liv Hospital Ulus Spec. MD. Osman Karlı Pediatrics Spec. MD. Tamer Ünver Liv Hospital Ulus Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU) Assoc. Prof. MD. Adem Dursun Liv Hospital Vadistanbul Assoc. Prof. MD. Adem Dursun Pediatrics Psyc. Selenay Yücel Keleş Liv Hospital Vadistanbul Psyc. Selenay Yücel Keleş Pediatric Psychology Spec. MD.  Fatih Aydın Liv Hospital Vadistanbul Spec. MD. Fatih Aydın Pediatrics Spec. MD. Dicle Çelik Liv Hospital Vadistanbul Spec. MD. Dicle Çelik Pediatrics Spec. MD. Elif Erdem Özcan Liv Hospital Vadistanbul Spec. MD. Elif Erdem Özcan Pediatrics Spec. MD. Hilal Kızıldağ Liv Hospital Vadistanbul Spec. MD. Hilal Kızıldağ Pediatrics Spec. MD. Mehmet Kılıç Liv Hospital Vadistanbul Spec. MD. Mehmet Kılıç Pediatrics Spec. MD. Ozan Uzunhan Liv Hospital Vadistanbul Spec. MD. Ozan Uzunhan Neonatology Spec. MD. Selami Bayrakdar Liv Hospital Vadistanbul Spec. MD. Selami Bayrakdar Pediatrics Spec. MD. Semra Akkuş Akman Liv Hospital Vadistanbul Spec. MD. Semra Akkuş Akman Pediatrics Asst. Prof. MD. Doruk Gül Liv Hospital Bahçeşehir Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases Prof. MD. Murat Sütçü Liv Hospital Bahçeşehir Prof. MD. Murat Sütçü Pediatric Health and Diseases Prof. MD. Nihat Demir Liv Hospital Bahçeşehir Prof. MD. Nihat Demir Pediatrics Psyc. (Psychologist) Buse Yağmur Liv Hospital Bahçeşehir Psyc. (Psychologist) Buse Yağmur Pediatric Psychology Spec. MD. Cansu Muluk Liv Hospital Bahçeşehir Spec. MD. Cansu Muluk Pediatrics Spec. MD. Dilek Hatipoğlu Liv Hospital Bahçeşehir Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases Spec. MD. Duygu Amine Garavi Liv Hospital Bahçeşehir Spec. MD. Duygu Amine Garavi Pediatrics Spec. MD. Fatih Kaya Liv Hospital Bahçeşehir Spec. MD. Fatih Kaya Pediatric Health and Diseases Spec. MD. Günel Nüsretzade Elmar Liv Hospital Bahçeşehir Spec. MD. Günel Nüsretzade Elmar Pediatrics Spec. MD. Mey Talip Liv Hospital Bahçeşehir Spec. MD. Mey Talip Pediatric Intensive Care Spec. MD. Negın Nahanmoghaddam Liv Hospital Bahçeşehir Spec. MD. Negın Nahanmoghaddam Pediatrics Spec. MD. Nushaba Abdullayeva Liv Hospital Bahçeşehir Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases Spec. MD. Refika İlbakan Hanımeli Liv Hospital Bahçeşehir Spec. MD. Refika İlbakan Hanımeli Pediatrics Spec. MD. Selman Alazab Liv Hospital Bahçeşehir Spec. MD. Selman Alazab Pediatrics Spec. MD. Özden Durmuş Gönültaş Liv Hospital Bahçeşehir Spec. MD. Özden Durmuş Gönültaş Pediatrics Spec. Md. Öznur Ceylan Liv Hospital Bahçeşehir Spec. Md. Öznur Ceylan Pediatric Health and Diseases Assoc. Prof. MD. Aslan Yılmaz Liv Hospital Topkapı Assoc. Prof. MD. Aslan Yılmaz Neonatology Prof. MD. Alpay Çakmak Liv Hospital Topkapı Prof. MD. Alpay Çakmak Pediatrics Spec. MD. Demet Deniz Bilgin Liv Hospital Topkapı Spec. MD. Demet Deniz Bilgin Pediatrics Spec. MD. Nesrin Köseoğlu Liv Hospital Topkapı Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry Spec. MD. Seçil Sözen Liv Hospital Topkapı Spec. MD. Seçil Sözen Pediatrics Spec. MD. Özge Akça Liv Hospital Topkapı Spec. MD. Özge Akça Pediatrics Spec. MD. Şeyma Öz Liv Hospital Topkapı Spec. MD. Şeyma Öz Pediatrics Asst. Prof. MD. Pakize Elif Alkış Liv Hospital Ankara Asst. Prof. MD. Pakize Elif Alkış Pediatrics Prof. MD. Musa Kazım Çağlar Liv Hospital Ankara Prof. MD. Musa Kazım Çağlar Pediatrics Prof. MD. İbrahim Hakan Bucak Liv Hospital Ankara Prof. MD. İbrahim Hakan Bucak Pediatrics Prof.MD. Sevgi Başkan Liv Hospital Ankara Prof.MD. Sevgi Başkan Pediatrics Spec. MD. Büşra Süzen Celbek Liv Hospital Ankara Spec. MD. Büşra Süzen Celbek Pediatrics Spec. MD. Galip Erdem Liv Hospital Ankara Spec. MD. Galip Erdem Pediatrics Spec. MD. Hafsa Uçur Liv Hospital Ankara Spec. MD. Hafsa Uçur Pediatric Health and Diseases Spec. MD. Hidayet Katipoğlu Liv Hospital Ankara Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases Spec. MD. Hüsniye Altan Liv Hospital Ankara Spec. MD. Hüsniye Altan Pediatrics Spec. MD. Mehmet Turfanda Liv Hospital Ankara Spec. MD. Mehmet Turfanda Pediatric Health and Diseases Spec. MD. Mustafa Yücel Kızıltan Liv Hospital Ankara Spec. MD. Mustafa Yücel Kızıltan Pediatrics Spec. MD.  Seral Navdar Liv Hospital Gaziantep Spec. MD. Seral Navdar Pediatric Health and Diseases Spec. MD. Gül Balyemez Liv Hospital Gaziantep Spec. MD. Gül Balyemez Pediatric Health and Diseases Spec. MD. Hasan Avşar Liv Hospital Gaziantep Spec. MD. Hasan Avşar Neonatology Spec. MD. Mert Çakır Liv Hospital Gaziantep Spec. MD. Mert Çakır Pediatrics Spec. MD. Saltuk Buğra Böke Liv Hospital Gaziantep Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases Spec. MD. Özlem Karaoğlu Liv Hospital Gaziantep Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases Spec. MD. İsmail Ersan Can Liv Hospital Gaziantep Spec. MD. İsmail Ersan Can Pediatric Health and Diseases Spec. MD. Şekibe Zehra Doğan Liv Hospital Gaziantep Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases Spec. MD. Gülsenem Sarı Aracı Liv Hospital Samsun Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases Spec. MD. Nazlı Karakullukcu Çebi Liv Hospital Samsun Spec. MD. Nazlı Karakullukcu Çebi Pediatrics Spec. MD. Nezih Akgün Liv Hospital Samsun Spec. MD. Nezih Akgün Pediatric Health and Diseases Spec. MD. Pelin Aytaç Uras Liv Hospital Samsun Spec. MD. Pelin Aytaç Uras Pediatrics MD. VEFA İSAYEVA Liv Bona Dea Hospital Bakü MD. VEFA İSAYEVA Pediatric Health and Diseases Spec. MD.  Elnur Hüseynov Liv Bona Dea Hospital Bakü Spec. MD. Elnur Hüseynov Pediatrics Spec. MD. INARE ELDAROVA Liv Bona Dea Hospital Bakü Spec. MD. INARE ELDAROVA Pediatrics Spec. MD. SADİQ İSMAYILOV Liv Bona Dea Hospital Bakü Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases MD. Dr. Elnur Hüseynov MD. Dr. Elnur Hüseynov Pediatrics Spec. MD. Doğa Sevinçok Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry Spec. MD. Sadık İsmayılov Pediatrics Spec. MD. Melike Akar Liv Hospital Bahçeşehir + Liv Hospital Topkapı Spec. MD. Melike Akar Pediatrics
Trusted Worldwide
30
Years of
Experience
30 Years Badge
Health Türkiye Accreditation

Trusted Worldwide

30 Years of Experience

Patient Reviews
Reviews from 9,651
4,9
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Book a Free Certified Online
Doctor Consultation

Clinics/branches
GDPR

We're Here to Help.
Get in Touch

Send us all your questions or requests, and our
expert team will assist you.

Our Doctors

Assoc. Prof. MD. Muhammet Ali Varkal Pediatrics

Assoc. Prof. MD. Muhammet Ali Varkal

Liv Hospital Ulus
Spec. MD. Gizem Güvener Pediatrics

Spec. MD. Gizem Güvener

Liv Hospital Ulus
Spec. MD. Osman Karlı Pediatrics

Spec. MD. Osman Karlı

Liv Hospital Ulus
Spec. MD. Tamer Ünver Neonatal Intensive Care Unit (NICU)

Spec. MD. Tamer Ünver

Liv Hospital Ulus
Assoc. Prof. MD. Adem Dursun Pediatrics

Assoc. Prof. MD. Adem Dursun

Liv Hospital Vadistanbul
Psyc. Selenay Yücel Keleş Pediatric Psychology

Psyc. Selenay Yücel Keleş

Liv Hospital Vadistanbul
Spec. MD.  Fatih Aydın Pediatrics

Spec. MD. Fatih Aydın

Liv Hospital Vadistanbul
Spec. MD. Dicle Çelik Pediatrics

Spec. MD. Dicle Çelik

Liv Hospital Vadistanbul
Spec. MD. Elif Erdem Özcan Pediatrics

Spec. MD. Elif Erdem Özcan

Liv Hospital Vadistanbul
Spec. MD. Hilal Kızıldağ Pediatrics

Spec. MD. Hilal Kızıldağ

Liv Hospital Vadistanbul
Spec. MD. Mehmet Kılıç Pediatrics

Spec. MD. Mehmet Kılıç

Liv Hospital Vadistanbul
Spec. MD. Ozan Uzunhan Neonatology

Spec. MD. Ozan Uzunhan

Liv Hospital Vadistanbul
Spec. MD. Selami Bayrakdar Pediatrics

Spec. MD. Selami Bayrakdar

Liv Hospital Vadistanbul
Spec. MD. Semra Akkuş Akman Pediatrics

Spec. MD. Semra Akkuş Akman

Liv Hospital Vadistanbul
Asst. Prof. MD. Doruk Gül Pediatric Health and Diseases

Asst. Prof. MD. Doruk Gül

Liv Hospital Bahçeşehir
Prof. MD. Murat Sütçü Pediatric Health and Diseases

Prof. MD. Murat Sütçü

Liv Hospital Bahçeşehir
Prof. MD. Nihat Demir Pediatrics

Prof. MD. Nihat Demir

Liv Hospital Bahçeşehir
Psyc. (Psychologist) Buse Yağmur Pediatric Psychology

Psyc. (Psychologist) Buse Yağmur

Liv Hospital Bahçeşehir
Spec. MD. Cansu Muluk Pediatrics

Spec. MD. Cansu Muluk

Liv Hospital Bahçeşehir
Spec. MD. Dilek Hatipoğlu Pediatric Health and Diseases

Spec. MD. Dilek Hatipoğlu

Liv Hospital Bahçeşehir
Spec. MD. Duygu Amine Garavi Pediatrics

Spec. MD. Duygu Amine Garavi

Liv Hospital Bahçeşehir
Spec. MD. Fatih Kaya Pediatric Health and Diseases

Spec. MD. Fatih Kaya

Liv Hospital Bahçeşehir
Spec. MD. Günel Nüsretzade Elmar Pediatrics

Spec. MD. Günel Nüsretzade Elmar

Liv Hospital Bahçeşehir
Spec. MD. Melike Akar Pediatrics

Spec. MD. Melike Akar

Liv Hospital Bahçeşehir
Liv Hospital Topkapı
Spec. MD. Mey Talip Pediatric Intensive Care

Spec. MD. Mey Talip

Liv Hospital Bahçeşehir
Spec. MD. Negın Nahanmoghaddam Pediatrics

Spec. MD. Negın Nahanmoghaddam

Liv Hospital Bahçeşehir
Spec. MD. Nushaba Abdullayeva Pediatric Health and Diseases

Spec. MD. Nushaba Abdullayeva

Liv Hospital Bahçeşehir
Spec. MD. Refika İlbakan Hanımeli Pediatrics

Spec. MD. Refika İlbakan Hanımeli

Liv Hospital Bahçeşehir
Spec. MD. Selman Alazab Pediatrics

Spec. MD. Selman Alazab

Liv Hospital Bahçeşehir
Spec. MD. Özden Durmuş Gönültaş Pediatrics

Spec. MD. Özden Durmuş Gönültaş

Liv Hospital Bahçeşehir
Spec. Md. Öznur Ceylan Pediatric Health and Diseases

Spec. Md. Öznur Ceylan

Liv Hospital Bahçeşehir
Assoc. Prof. MD. Aslan Yılmaz Neonatology

Assoc. Prof. MD. Aslan Yılmaz

Liv Hospital Topkapı
Prof. MD. Alpay Çakmak Pediatrics

Prof. MD. Alpay Çakmak

Liv Hospital Topkapı
Spec. MD. Demet Deniz Bilgin Pediatrics

Spec. MD. Demet Deniz Bilgin

Liv Hospital Topkapı
Spec. MD. Nesrin Köseoğlu Pediatric and Adolescent Psychiatry

Spec. MD. Nesrin Köseoğlu

Liv Hospital Topkapı
Spec. MD. Seçil Sözen Pediatrics

Spec. MD. Seçil Sözen

Liv Hospital Topkapı
Spec. MD. Özge Akça Pediatrics

Spec. MD. Özge Akça

Liv Hospital Topkapı
Spec. MD. Şeyma Öz Pediatrics

Spec. MD. Şeyma Öz

Liv Hospital Topkapı
Asst. Prof. MD. Pakize Elif Alkış Pediatrics

Asst. Prof. MD. Pakize Elif Alkış

Liv Hospital Ankara
Prof. MD. Musa Kazım Çağlar Pediatrics

Prof. MD. Musa Kazım Çağlar

Liv Hospital Ankara
Prof. MD. İbrahim Hakan Bucak Pediatrics

Prof. MD. İbrahim Hakan Bucak

Liv Hospital Ankara
Prof.MD. Sevgi Başkan Pediatrics

Prof.MD. Sevgi Başkan

Liv Hospital Ankara
Spec. MD. Büşra Süzen Celbek Pediatrics

Spec. MD. Büşra Süzen Celbek

Liv Hospital Ankara
Spec. MD. Galip Erdem Pediatrics

Spec. MD. Galip Erdem

Liv Hospital Ankara
Spec. MD. Hafsa Uçur Pediatric Health and Diseases

Spec. MD. Hafsa Uçur

Liv Hospital Ankara
Spec. MD. Hidayet Katipoğlu Pediatric Health and Diseases

Spec. MD. Hidayet Katipoğlu

Liv Hospital Ankara
Spec. MD. Hüsniye Altan Pediatrics

Spec. MD. Hüsniye Altan

Liv Hospital Ankara
Spec. MD. Mehmet Turfanda Pediatric Health and Diseases

Spec. MD. Mehmet Turfanda

Liv Hospital Ankara
Spec. MD. Mustafa Yücel Kızıltan Pediatrics

Spec. MD. Mustafa Yücel Kızıltan

Liv Hospital Ankara
Spec. MD.  Seral Navdar Pediatric Health and Diseases

Spec. MD. Seral Navdar

Liv Hospital Gaziantep
Spec. MD. Gül Balyemez Pediatric Health and Diseases

Spec. MD. Gül Balyemez

Liv Hospital Gaziantep
Spec. MD. Hasan Avşar Neonatology

Spec. MD. Hasan Avşar

Liv Hospital Gaziantep
Spec. MD. Mert Çakır Pediatrics

Spec. MD. Mert Çakır

Liv Hospital Gaziantep
Spec. MD. Saltuk Buğra Böke Pediatric Health and Diseases

Spec. MD. Saltuk Buğra Böke

Liv Hospital Gaziantep
Spec. MD. Özlem Karaoğlu Pediatric Health and Diseases

Spec. MD. Özlem Karaoğlu

Liv Hospital Gaziantep
Spec. MD. İsmail Ersan Can Pediatric Health and Diseases

Spec. MD. İsmail Ersan Can

Liv Hospital Gaziantep
Spec. MD. Şekibe Zehra Doğan Pediatric Health and Diseases

Spec. MD. Şekibe Zehra Doğan

Liv Hospital Gaziantep
Spec. MD. Gülsenem Sarı Aracı Pediatric Health and Diseases

Spec. MD. Gülsenem Sarı Aracı

Liv Hospital Samsun
Spec. MD. Nazlı Karakullukcu Çebi Pediatrics

Spec. MD. Nazlı Karakullukcu Çebi

Liv Hospital Samsun
Spec. MD. Nezih Akgün Pediatric Health and Diseases

Spec. MD. Nezih Akgün

Liv Hospital Samsun
Spec. MD. Pelin Aytaç Uras Pediatrics

Spec. MD. Pelin Aytaç Uras

Liv Hospital Samsun
MD. VEFA İSAYEVA Pediatric Health and Diseases

MD. VEFA İSAYEVA

Liv Bona Dea Hospital Bakü
Spec. MD.  Elnur Hüseynov Pediatrics

Spec. MD. Elnur Hüseynov

Liv Bona Dea Hospital Bakü
Spec. MD. INARE ELDAROVA Pediatrics

Spec. MD. INARE ELDAROVA

Liv Bona Dea Hospital Bakü
Spec. MD. SADİQ İSMAYILOV Pediatric Health and Diseases

Spec. MD. SADİQ İSMAYILOV

Liv Bona Dea Hospital Bakü
MD. Dr. Elnur Hüseynov Pediatrics

MD. Dr. Elnur Hüseynov

Spec. MD. Doğa Sevinçok Pediatric and Adolescent Psychiatry

Spec. MD. Doğa Sevinçok

Pediatrics

Spec. MD. Sadık İsmayılov

Related Videos

Need Help? Chat with our medical team

Let's Talk on WhatsApp

📌

Get instant answers from our medical team. No forms, no waiting — just tap below to start chatting now.

or call us at +90 530 510 67 91